Skip to main content
Margaret McElrath, MD, Infectious Disease, Seattle, WA

Margaret Juliana McElrath MD


Professor, Medicine, University of Washington School of Medicine

Join to View Full Profile
  • Ambulatory Clinic825 Eastlake Avenue EastSeattle, WA 98109

  • Phone+1 206-288-1000

Are you Dr. McElrath?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 11 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Margaret McElrath, MD is an infectious disease specialist in Seattle, Washington. She is currently licensed to practice medicine in Washington and South Carolina. She is a Professor at University of Washington School of Medicine.

Education & Training

  • University of South Carolina School of Medicine
    University of South Carolina School of MedicineClass of 1980

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 1989 - 2027
  • SC State Medical License
    SC State Medical License 1981 - 1983
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

Grant Support

  • Immune Responses to Malaria, HIV and SARS-CoV-2 Infection and ImmunizationSEATTLE CHILDREN'S HOSPITAL2017–2027
  • Seattle-Lausanne Clinical Trials UnitFRED HUTCHINSON CANCER CENTER2007–2027
  • HIV Vaccine Trials Network Laboratory CenterFRED HUTCHINSON CANCER CENTER2006–2027
  • CoVPN 3008 Multi-Center, Randomized, Efficacy Study of Early vs Deferred Vaccination with COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern - LC RepositoryFRED HUTCHINSON CANCER CENTER2006–2025
  • CoVPN 3008 Multi-Center, Randomized, Efficacy Study of Early vs Deferred Vaccination with COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern - LC GY18FRED HUTCHINSON CANCER CENTER2006–2025